ly 255283 has been researched along with paclitaxel in 1 studies
Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
54 | 0 | 15 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, H; Kim, JH; Lee, JE; Park, GS | 1 |
1 other study(ies) available for ly 255283 and paclitaxel
Article | Year |
---|---|
A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukotriene Antagonists; Mice; Mice, Nude; Paclitaxel; Receptors, Leukotriene B4; RNA, Small Interfering; Tetrazoles; Xenograft Model Antitumor Assays | 2013 |